SciELO - Scientific Electronic Library Online

 
vol.31 número2Variantes genotípicas del SNP-19 del gen de la CAPN 10 y su relación con la diabetes mellitus tipo 2 en una población de Ciudad Juárez, MéxicoEfectos de un suplemento hipercalórico e hiperprotéico enriquecida con ácidos grasos w3 y fibra en pacientes ambulatorios postquirúrgicos con cáncer de cabeza y cuello índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

BERING, Tatiana; FERNANDES MAURICIO, Silvia; SILVA, Jacqueline Braga da  y  CORREIA, Maria Isabel Toulson Davisson. Nutritional and metabolic status of breast cancer women. Nutr. Hosp. [online]. 2015, vol.31, n.2, pp.751-758. ISSN 1699-5198.  https://dx.doi.org/10.3305/nh.2015.31.2.8056.

Introduction: The nutritional and metabolic status have been related to cancer risk factors as well as to cancer treatment morbimortality. Thus, its assessment is important for developing strategies for the promotion, maintenance and / or recovery of nutritional status and cancer outcome. Material and methods: Several different methods for nutritional assessment in breast cancer patients undergoing adjuvant therapy were used, including subjective global assessment (SGA), body mass index (BMI), triceps skinfold (TSF), mid-arm circumference (MAC), adductor pollicis muscle thickness (APMT), hand grip strength (HGS) and bioelectrical impedance analysis (BIA). The presence of metabolic syndrome (MetS) was also evaluated. The occurrence of complications during cancer treatment versus the nutritional status was assessed. Results: We followed 78 women with a mean age of 53.2 ± 11.6 years. Most patients were considered well nourished (80.8%). Excessive body fat mass by BIA and MetS were found in 80,8 % and 41.9% of the patients respectively. There were significant differences in BMI, TSF, WC (waist circumference) and % fat mass between patients with and without MetS. Most patients experienced complications during cancer treatment, but there was no association with nutritional or metabolic status. Conclusion: In breast cancer women undergoing adjuvant therapy, the prevalence of metabolic syndrome was high and, on the contrary, undernutrition was low. There were no short-term effects of metabolic syndrome or undernutrition on clinical outcomes.

Palabras clave : Breast cancer; Nutritional status; Metabolic syndrome.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons